Showing results (21-30 of 5,251) with videos related to

Sort By:
Pageof 526
Oncology|November 28, 2014
Recent progress in radiofrequency ablation therapy for hepatocellular carcinomaKenji Ikeda, Yukio Osaki, Hiroyuki Nakanishi, et al.
Oncology|November 28, 2014
Characteristics of long-term survivors following sorafenib treatment for advanced hepatocellular carcinoma: report of a workshop at the 50th Annual Meeting of the Liver Cancer Study Group of JapanKatsuaki Tanaka, Mitsuo Shimada, Masatoshi Kudo
Oncology|January 1, 1989
Double-blind randomized cross-over trial of dexamethasone and prochlorperazine as anti-emetics for cancer chemotherapyD Goldstein, J A Levi, R L Woods, et al.
Oncology|January 1, 1989
Substance immunologically cross-reactive with insulin (SICRI) stimulates cell divisionM Osmak, M Sirotkovic, S Levanat, et al.
Oncology|January 1, 1989
Chlorpromazine and dexamethasone versus high-dose metoclopramide and dexamethasone in patients receiving cancer chemotherapy, particularly cis-platinum: a prospective randomized crossover studyE Gez, R Ben-Yosef, R Catane, et al.
Oncology|June 16, 2016
Unexpected Side Effects of a High S-1 Dose: Subanalysis of a Phase III Trial Comparing Gemcitabine, S-1 and Combinatorial Treatments for Advanced Pancreatic CancerSatoshi Kobayashi, Makoto Ueno, Hiroki Hara, et al.
Oncology|May 28, 2016
A Phase II Study of Third-Line Combination Chemotherapy with Bevacizumab Plus S-1 for Metastatic Colorectal Cancer with Mutated KRAS (SAVIOR Study)Motoki Yoshida, Akinori Takagane, Yasuhiro Miyake, et al.
Oncology|April 28, 2016
Metastatic Gastroesophageal Adenocarcinoma Patients Treated with Systemic Therapy Followed by Consolidative Local Therapy: A Nomogram Associated with Long-Term SurvivorsHironori Shiozaki, Rebecca S Slack, Hsiang-Chun Chen, et al.
Oncology|January 1, 1989
Influence of adjuvant chemotherapy for operable breast cancer on results of treatment at relapseS Noguchi, K Miyauchi, Y Nishizawa, et al.
Oncology|January 1, 1989
Phase II trial of recombinant alpha-2b interferon in the treatment of metastatic skin melanomaM R Sertoli, M G Bernengo, A Ardizzoni, et al.
Pageof 526